ARTICLE | Clinical News
Sodium oxybate regulatory update
December 21, 2009 8:00 AM UTC
Jazz submitted an NDA to FDA for sodium oxybate to treat fibromyalgia. UCB Group (Euronext:UCB, Brussels, Belgium) has exclusive commercialization rights to the oral liquid formulation of sodium salt...